DexCom, Inc. (DXCM)
$79.41-5.05-5.98%Nov 6
Loading chart…
M.Cap$29.6B
Dividends—
Next report—
Forecast
Target
P/E30.5
P/S5.76
P/B11.68
5-y avg sales growth+19.3%
Debt / EBITDA1.02
ROE30.5%
Altman Z-score6.43 (safe)
RSI39
MFI37
Price / MA50-6.8% (low) ↓
Trend pattern
Financial Statements
No data available
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
About

DexCom, Inc. is a medical device company that creates and sells continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. Their products include DexCom G6, Real-Time API, ONE, and Share, with their upcoming product being DexCom G7, a newer CGM system. They collaborate and have a partnership with Verily Life Sciences LLC and Verily Ireland Limited.

https://www.dexcom.com
Beta 1.44